GLP-1 Agonists Rapamycin and GLP-1 have hugely differing mechanisms of actions and longevity benefits
Both are prescribed and monitored
Orandi At 5 years of follow-up, significantly fewer GLP-1 drug users (7.5%) than nonusers (12.2%) experienced death-censored graft loss, for a 49% lower risk for graft loss with GLP-1 drug use when adjusted for insulin use (adjusted subhazard ratio [aSHR] = 0.51
One practical takeaway: because both brands rest on the same molecules, the more useful comparison is not which name is stronger but which onboarding, provider access, and support cadence fits your situation
By optimizing mitochondrial function and reducing oxidative stress, glutathione supports mental clarity and cognitive performance, enhancing overall well-being
Berberine, a herbal metabolite in the metabolic syndrome: The risk factors, course, and consequences of the disease